Dou, Yun-Ling <br/><br/>
Midazolam inhibits the proliferation of human head and neck squamous carcinoma cells by downregulating p300 expression.  [electronic resource] 

 -  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine  Aug 2014 
 - 7499-504 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0380 
<br/><br/><label>Standard No.: </label>10.1007/s13277-014-1991-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Proliferation--drug effects<br/>Down-Regulation<br/>E1A-Associated p300 Protein--antagonists & inhibitors<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Hypopharyngeal Neoplasms--drug therapy<br/>Midazolam--pharmacology<br/>Retinoblastoma Protein--physiology<br/>Squamous Cell Carcinoma of Head and Neck<br/>Tumor Cells, Cultured